| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 495 | 13.683 | 7.201 | 77.838 | 92.259 | 21.946 | 28.178 |
| Total Income - EUR | - | - | - | 495 | 13.683 | 7.837 | 79.092 | 94.705 | 24.066 | 29.452 |
| Total Expenses - EUR | - | - | - | 25 | 3.290 | 3.683 | 56.628 | 44.005 | 24.903 | 28.160 |
| Gross Profit/Loss - EUR | - | - | - | 470 | 10.393 | 4.154 | 22.464 | 50.700 | -838 | 1.292 |
| Net Profit/Loss - EUR | - | - | - | 455 | 9.982 | 3.956 | 20.393 | 48.071 | -1.117 | 244 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Derma Innovation S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 162 | 0 | 0 | 21.151 | 20.066 | 14.652 | 27.485 |
| Current Assets | - | - | - | 545 | 11.821 | 15.128 | 34.043 | 53.792 | 51.601 | 49.866 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 495 | 1.072 | 448 | 7.732 | 1.748 | 974 | 3.146 |
| Cash | - | - | - | 49 | 10.749 | 14.681 | 26.311 | 52.044 | 50.627 | 46.721 |
| Shareholders Funds | - | - | - | 498 | 10.471 | 14.228 | 34.306 | 60.846 | 55.237 | 55.173 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 208 | 1.711 | 931 | 20.888 | 13.011 | 11.104 | 22.238 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Derma Innovation S.r.l.